Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Cerecor announces promising final results from phase I study of CERC-301

July 2, 2019

Phase III study of sildenafil in newborns with PPHN does not meet primary efficacy endpoint

July 1, 2019

Bayer initiates phase II AVANTI study of BAY-1753011 in congestive heart failure

July 1, 2019

BR-11257, a novel nonstabilizing soluble guanylyl cyclase partial agonist

July 1, 2019

CD28 unveiled as potential therapeutic target for giant-cell arteritis

June 28, 2019

Arena Pharmaceuticals divulges beta3-adrenoceptor antagonists

June 28, 2019

Metabolic enzyme targeting takes on pulmonary hypertension

June 28, 2019

BIAL-Portela discloses DBH inhibitors

June 27, 2019

Faron reports interim data from phase II INFORAAA study of Traumakine

June 26, 2019

Dosing starts in phase I study of gene therapy to treat Danon disease

June 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...